Overview
ISO 15378:2017/Amd 1:2024 is an important international standard addressing primary packaging materials for medicinal products. This amendment to ISO 15378:2017 integrates climate action considerations into the existing framework that applies ISO 9001:2015 quality management requirements alongside good manufacturing practice (GMP). Developed by ISO Technical Committee ISO/TC 76, this amendment reflects a growing emphasis on sustainability and environmental responsibility in the pharmaceutical packaging industry.
The update introduces specific requirements aimed at helping organizations identify and address climate change as a relevant factor in their quality management systems and GMP practices for medicinal product packaging. This aligns packaging manufacturers with global climate action initiatives while maintaining the highest standards for product safety and quality.
Key Topics
-
Integration of Climate Action
Organizations must assess whether climate change is a relevant issue impacting their operations related to primary packaging materials. This proactive evaluation is essential for aligning quality and manufacturing processes with environmental sustainability goals.
-
Extension of ISO 9001:2015 and GMP Requirements
The amendment adds clauses that expand upon existing ISO 9001:2015 quality management system requirements, explicitly including climate-related considerations in risk management, stakeholder engagement, and operational control.
-
Engagement with Interested Parties
The update highlights the importance of recognizing that external stakeholders, such as regulators, customers, and communities, may have climate-related requirements linked to packaging materials, necessitating their inclusion in organizational planning and compliance efforts.
-
Maintenance of Product Quality and Safety
While incorporating climate action, the standard ensures that organizations maintain stringent quality and good manufacturing practices to guarantee the integrity and safety of medicinal product packaging.
Applications
ISO 15378:2017/Amd 1:2024 is primarily applicable to manufacturers and suppliers involved in the design, production, and supply of primary packaging materials for medicinal products. Key applications include:
-
Pharmaceutical Packaging Manufacturers
Ensuring compliance with enhanced quality and environmental management controls that address climate risks, boosting market credibility and regulatory compliance.
-
Quality Management System (QMS) Auditors
Incorporating climate action criteria into audits of packaging material suppliers to verify alignment with both ISO 9001:2015 and GMP requirements.
-
Regulatory and Compliance Teams
Using the standard to anticipate and meet climate-related regulatory requirements tied to pharmaceutical packaging production.
-
Sustainability and Environmental Officers
Guiding organizational strategies to integrate climate risk assessments and mitigation measures within existing quality and manufacturing management frameworks.
Related Standards
Organizations implementing ISO 15378:2017/Amd 1:2024 should also consider the following standards for comprehensive quality and environmental management:
-
ISO 9001:2015 – Quality management systems Requirements, forming the foundational standard for quality assurance and continual improvement.
-
ISO 14001:2015 – Environmental management systems, which can complement ISO 15378 by providing a broader framework for environmental responsibility including climate action.
-
Good Manufacturing Practice (GMP) guidelines – Industry-specific GMP requirements that ensure safety and quality in pharmaceutical production.
-
ISO 15378:2017 – The original edition outlining the particular requirements for primary packaging materials, serving as the basis for this amendment.
Conclusion
ISO 15378:2017/Amd 1:2024 is a critical update that embeds climate action and environmental considerations into the quality management and GMP framework for primary packaging materials used in medicinal products. Adoption of this amendment supports pharmaceutical packaging manufacturers in transitioning towards more sustainable practices, meeting rising regulatory and stakeholder expectations, and ensuring ongoing product safety and quality in the face of global climate challenges.
By integrating these climate-related requirements, organizations demonstrate responsible environmental stewardship in pharmaceutical packaging, reinforcing their commitment to both regulatory excellence and sustainability.
Open preview (PDF)Primary packaging materials for medicinal products — Particular requirements for the application of ISO 9001:2015, with reference to good manufacturing practice (GMP) — Amendment 1: Climate action changes
